Medicare Enrolled

Dr. Kenneth Herman, D.O.

Dermatology · Woodbury, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
17 W RED BANK AVE, Woodbury, NJ 08096
8568530900
In practice since 2005 (20 years)
NPI: 1013998756 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Herman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Herman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Herman

Dr. Kenneth Herman is a dermatology specialist in Woodbury, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Herman performed 4,215 Medicare services across 2,192 unique beneficiaries.

Between the years covered by Open Payments, Dr. Herman received a total of $86,053 from 37 pharmaceutical and/or device companies across 769 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Herman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 25% volume in NJ $86,053 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,215
Medicare services
Top 25% in NJ for dermatology
2,192
Unique beneficiaries
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~211 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
1,405 $5 $25
Tissue pathology examination, moderate complexity
A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue.
990 $29 $60
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
386 $43 $104
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
377 $43 $120
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
272 $64 $160
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
182 $1 $5
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
160 $87 $211
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
69 $68 $275
Destruction of 15 or more precancerous skin growths
This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer.
62 $139 $440
New patient office visit, 15-29 minutes
An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold.
56 $50 $130
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
37 $10 $75
Pathology tissue examination, moderate complexity
A laboratory test where a pathologist examines tissue samples under a microscope to identify abnormalities. This specific level indicates a moderate degree of complexity in the analysis.
35 $10 $60
Shaving of skin growth, 0.6-1.0 cm
A minor procedure to shave off a skin growth on the body, arms, or legs that measures between 0.6 and 1.0 centimeters.
32 $93 $222
Shaving of skin growth on face, 0.6-1.0 cm
This procedure involves shaving off a skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the growth being removed is between 0.6 and 1.0 centimeters.
26 $99 $250
Destruction of cancer skin growth, 1.1-2.0 cm
Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters.
21 $148 $300
Shaving of skin growth, 1.1-2.0 cm
This procedure involves shaving off a skin growth measuring between 1.1 and 2.0 centimeters from the body, arms, or legs.
20 $105 $250
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
20 $98 $280
Injection into skin growths, 1-7
A procedure involving the injection of medication into one to seven skin growths.
18 $38 $120
Destruction of cancerous skin growth on face, 0.6-1.0 cm
This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 0.6 and 1.0 centimeters in diameter.
17 $146 $330
Shaving of skin growth, 0.6-1.0 cm
A minor procedure to shave off a skin growth measuring 0.6 to 1.0 cm from the scalp, neck, hands, feet, or genitals.
16 $99 $225
Destruction of cancer skin growth, 0.6-1.0 cm
This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that measures between 0.6 and 1.0 centimeters.
14 $114 $264
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$86,053
Total received (2018-2024)
Avg $12,293/year across 7 years
Top 5% in NJ for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
769
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$74,146 (86.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,908 (13.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,868
2023
$7,402
2022
$14,204
2021
$13,338
2020
$8,612
2019
$23,786
2018
$15,844

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$591
Arcutis Biotherapeutics, Inc.
$374
Regeneron Healthcare Solutions, Inc.
$277
ABBVIE INC.
$274
E.R. Squibb & Sons, L.L.C.
$236
Lilly USA, LLC
$222
Novartis Pharmaceuticals Corporation
$192
Janssen Biotech, Inc.
$156
SUN PHARMACEUTICAL INDUSTRIES INC.
$147
Incyte Corporation
$131
LEO Pharma Inc.
$72
PFIZER INC.
$63
GENZYME CORPORATION
$35
Dermavant Sciences, Inc.
$29
Amgen Inc.
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
Verrica Pharmaceuticals Inc.
$17
Ortho Dermatologics, a division of Bausch Health US, LLC
$14
Top 3 companies account for 43.3% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$37,133
Celgene Corporation
$36,028
Lilly USA, LLC
$1,566
ABBVIE INC.
$1,448
Ortho Dermatologics, a division of Bausch Health US, LLC
$1,113
UCB, Inc.
$964
Novartis Pharmaceuticals Corporation
$943
Encore Dermatology Inc.
$795
Regeneron Healthcare Solutions, Inc.
$699
LEO Pharma Inc.
$660
Janssen Biotech, Inc.
$657
PFIZER INC.
$511
E.R. Squibb & Sons, L.L.C.
$483
Arcutis Biotherapeutics, Inc.
$420
Incyte Corporation
$386
GENZYME CORPORATION
$284
AbbVie, Inc.
$250
AbbVie Inc.
$249
Galderma Laboratories, L.P.
$237
SUN PHARMACEUTICAL INDUSTRIES INC.
$235
Genentech USA, Inc.
$193
Sun Pharmaceutical Industries Inc.
$158
Almirall LLC
$130
Boehringer Ingelheim Pharmaceuticals, Inc.
$85
SANOFI-AVENTIS U.S. LLC
$72
EPI Health, LLC
$62
Biofrontera Inc.
$49
DUSA Pharmaceuticals, Inc.
$49
Aclaris Therapeutics, Inc.
$42
Dermavant Sciences, Inc.
$29
Journey Medical Corporation
$29
Sandoz Inc.
$27
Verrica Pharmaceuticals Inc.
$17
Mylan Pharmaceuticals Inc.
$14
Mission Pharmacal Company
$14
Taro Pharmaceuticals USA, Inc.
$12
Exeltis, USA Inc.
$11
Top 3 companies account for 86.8% of all-time payments
Associated products mentioned in payments ›
20% · ADBRY · ALTRENO · AMELUZ · APEXICON E · ARAZLO · Absorica LD · Ameluz · Avar · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · Bimzelx · CIBINQO · CLODERM · COSENTYX · Ceracade · Cimzia · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EFUDEX · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Enbrel · Erivedge · Exelderm · FINACEA · HALOG OINTMENT (Halcinonide Ointment · HUMIRA · Humira · ILUMYA · Ilumya · Impoyz · JUBLIA · KERYDIN · Klisyri · LEVULAN KERASTICK · LIBTAYO · LITFULO · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · Neocera · OLUMIANT · ONEXTON · OPZELURA · ORACEA · Olux-E · Otezla · PICATO · REMICADE · RETIN-A-MICRO · RHOFADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · SPEVIGO · Seysara · Sitavig · Skyrizi · Sotyktu · TALTZ · TARGRETIN · TREMFYA · USP) 0.1% · VTAMA · Winlevi · YCANTH · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (86%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in dermatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for dermatology in NJ.

Looking for a dermatology specialist in Woodbury?
Compare dermatologists in the Woodbury area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
313
Per 100K population
102.8
County median income
$102,807
Nearest hospital
NORTHBROOK BEHAVIORAL HEALTH HOSPITAL
5.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Herman is a clinical cardiology specialist, with above-average Medicare volume (top 25% in NJ), with speaking/promotional industry engagement in the top 5% of NJ peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Herman experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Herman performed 1,405 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Herman receive payments from pharmaceutical companies?
Yes. Dr. Herman received a total of $86,053 from 37 companies across 769 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Herman's costs compare to other dermatologists in Woodbury?
Dr. Herman's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Herman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →